Treatment of murine pulmonary cryptococcosis with a combination of fluconazole and interleukin-12

Journal of Infection and Chemotherapy

Volumn 2, Issue 3, 1996, Pages 156-160

  Kawakami, Kazuyoshi ^a   Tohyama, Masaki ^a   Xie, Qifeng ^a   Saito, Atsushi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Cryptococcus neoformans; Fluconazole; IL 12; Pulmonary infection

Indexed keywords

EID: 0142025430     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02351568     Document Type: Article

References (20)

1. Stevens DA. Fungal infections in AIDS patients. Br J Clin Pract 1990;44 (suppl l):11-22.
2. Georgopapadakou NH, Walsh TJ. Antifungal agents: chemotherapeutic targets and immunologic strategies. Antimicrob Agents Chemother 1996;40:279-291.
3. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-276.
4. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, et al. Induction of IFN-γ production by NK cell stimulatory factor (NKSF): characterization of the responder cells and synergy with other inducers. J Exp Med 1991;173:869-879.
5. Skeen MJ, Ziegler HK. Activation of γδT cells for production of IFN-γ is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12. J Immunol 1995;154: 5832-5841.
6. Hsieh C, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Listeria-induced Th1 development in αβ-TCR transgenic CD4+T cells occurs through macrophage production of IL-12. Science 1993; 260: 547-549.
7. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
8. Tripp CS, Gately MK, Hakimi J, Ling P, Unannue ER. Neutralization of IL-12 decreases resistance to Listeria in SCID and CB-17 mice. Reversal by IFN-γ. J Immunol 1994;152:1883-1887.
9. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, et al. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 1994;153:2533-2543.
10. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK. Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 1993;177:1505-1509.
11. Romani L, Mencacci A, Tonnetti L, Spaccapelo R, Conci E, Puccetti P, et al. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J Immunol 1994;152:5167-5175.
12. Kawakami K, Tohyama M, Xie Q, Saito A. Interleukin-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin Exp Immunol 1996;104:208-214.
13. Kozel TR. Cryptococcosis. In: Murphy JW, Friedman H, Bendinelli M (eds) Fungal infection and immune responses. New York: Plenum Press, 1993:277-302.
14. Clerici M, Shearer GM. A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
15. Daynes RA, Araneo BA. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol 1989;19:2319-2325.
16. Clemons KV, Brummer E, Stevens DA. Cytokine treat-ment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob Agents Chemother 1994;38:460-464.
17. Nabors GS, Afonso LCC, Farrell JP, Scott P. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proc Natl Acad Sci USA 1995;92:3142-3146.
18. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 1992;257:539-542.
19. Burstein HJ, Abbas AK. In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J Exp Med 1993;177:457-463.
20. Trinchieri G, Scott P. The role of interleukin 12 in the immune response, disease and therapy. Immunol Today 1994;15:460-463.